Page last updated: 2024-09-05

osemozotan and bemesetron

osemozotan has been researched along with bemesetron in 1 studies

Compound Research Comparison

Studies
(osemozotan)
Trials
(osemozotan)
Recent Studies (post-2010)
(osemozotan)
Studies
(bemesetron)
Trials
(bemesetron)
Recent Studies (post-2010) (bemesetron)
3204254325

Protein Interaction Comparison

ProteinTaxonomyosemozotan (IC50)bemesetron (IC50)
5-hydroxytryptamine receptor 3EHomo sapiens (human)0.0093
5-hydroxytryptamine receptor 3BHomo sapiens (human)0.0093
5-hydroxytryptamine receptor 3ARattus norvegicus (Norway rat)0.097
5-hydroxytryptamine receptor 3AHomo sapiens (human)0.0928
5-hydroxytryptamine receptor 3DHomo sapiens (human)0.0093
5-hydroxytryptamine receptor 3CHomo sapiens (human)0.0093
5-hydroxytryptamine receptor 3BRattus norvegicus (Norway rat)0.097

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, S; Baba, A; Matsuda, T; Somboonthum, P; Suzuki, M; Takuma, K1

Other Studies

1 other study(ies) available for osemozotan and bemesetron

ArticleYear
Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation.
    British journal of pharmacology, 1995, Volume: 115, Issue:4

    Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Dioxanes; Dioxoles; Drug Interactions; Hippocampus; Hypothalamus; Injections, Subcutaneous; Male; Microdialysis; Neurons; Norepinephrine; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tropanes

1995